PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32004752-11	2020	We also show that ionising radiation at 5 Gy results in phosphorylation of p53 at serine 15, a key phosphorylation site for p53-mediated apoptosis, and that hypoxia attenuates this phosphorylation.	cholecystokinin C-terminal flanking peptide	82-88	tumor protein p53	Homo sapiens	75-78	
32004752-11	2020	We also show that ionising radiation at 5 Gy results in phosphorylation of p53 at serine 15, a key phosphorylation site for p53-mediated apoptosis, and that hypoxia attenuates this phosphorylation.	cholecystokinin C-terminal flanking peptide	82-88	tumor protein p53	Homo sapiens	124-127	
32035620-0	2020	Crotonylation at serine 46 impairs p53 activity.	cholecystokinin C-terminal flanking peptide	17-23	tumor protein p53	Homo sapiens	35-38	
32035620-4	2020	Surprisingly this crotonylation targets serine 46, instead of any predicted lysine residues, of p53, as detected in TCEP-probe labeled crotonylation and anti-crotonylated peptide antibody reaction assays.	cholecystokinin C-terminal flanking peptide	40-46	tumor protein p53	Homo sapiens	96-99	
32035620-7	2020	Since serine 46 is only found in human p53, our studies unveil an unconventional PTM unique for human p53, impairing its activity in response to CA.	cholecystokinin C-terminal flanking peptide	6-12	tumor protein p53	Homo sapiens	39-42	
32035620-7	2020	Since serine 46 is only found in human p53, our studies unveil an unconventional PTM unique for human p53, impairing its activity in response to CA.	cholecystokinin C-terminal flanking peptide	6-12	tumor protein p53	Homo sapiens	102-105	
31680191-6	2020	Specifically, lysine 370/372/373 and 381/382/386 mutations decreased p53 stability, and lysine 305 mutation reduced p53 phosphorylation level at serine 15, while lysine 120 and 164 mutations decreased p53 acetylation level at lysine 382.	cholecystokinin C-terminal flanking peptide	145-151	tumor protein p53	Homo sapiens	116-119	
31680191-6	2020	Specifically, lysine 370/372/373 and 381/382/386 mutations decreased p53 stability, and lysine 305 mutation reduced p53 phosphorylation level at serine 15, while lysine 120 and 164 mutations decreased p53 acetylation level at lysine 382.	cholecystokinin C-terminal flanking peptide	145-151	tumor protein p53	Homo sapiens	116-119